StocksMedium•22 October 2026•
1 min read
Quest Diagnostics Beats Q3 Estimates and Raises Full-Year Profit Outlook
Key Facts
1Quest Diagnostics reported Q3 revenues of $3.10 billion, a 10% increase compared to the previous year.
2The company raised its full-year 2026 adjusted diluted EPS guidance to a range of $11.25 to $11.35.
Quest Diagnostics reported adjusted earnings per share of $3.00 for the third quarter ending September 30, 2026, beating analyst expectations by $0.13. According to a statement released via PR Newswire, revenue reached $3.10 billion, exceeding estimates by $50 million and representing a 10% year-over-year increase.
DGX closed at $238.93 on October 21, 2026, after reaching a session high of $240.56. Following the performance, the company raised its full-year 2026 adjusted EPS guidance to a range of $11.25 to $11.35, citing strong organic growth across physician and hospital channels.